If you take Wegovy, can you stop — and what happens when you do?

Does your appetite come back after stopping Wegovy?

For most people, yes, and fairly quickly. Semaglutide works by activating GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing hunger signals. Once you stop injecting, those signals are no longer being moderated by the medicine. The feeling of fullness that came more easily on treatment fades, and appetite returns broadly to where it was before you started.

The speed varies between individuals, but it is not a gradual drift over months. Many people describe noticing the change within days of their last injection. If you were on a higher maintenance dose, the shift can feel more pronounced simply because the contrast with treatment is sharper. This is not a side effect or a withdrawal, it is the medicine's mechanism running in reverse.

One thing worth knowing: the clinical profile of semaglutide was studied in this respect. Participants who stopped after the STEP 1 trial regained most of their lost weight over the following year, which is why guidance from NHS England frames these medicines as long-term treatments rather than short courses. That does not mean stopping is wrong, it means stopping needs a plan.

Is weight regain after stopping Wegovy inevitable?

Not entirely, but the evidence is sobering. The STEP 1 trial, published in the New England Journal of Medicine, included a follow-up phase after participants stopped semaglutide: by one year post-treatment, a large proportion of the weight lost during the trial had returned. This pattern is consistent across GLP-1 medicines. Obesity is a chronic condition with a strong biological component, the medicine addresses the biology while it is present; stopping removes that correction.

How much weight comes back depends on several factors: how long you were on treatment, what lifestyle habits you built during that time, and whether you had any ongoing medical support. People who maintained regular physical activity and a consistent eating pattern during treatment tend to fare better, though even they typically see some regain. If you are weighing up whether continued treatment is sustainable, the cost context for Wegovy is a practical part of that conversation.

The NICE recommendation for semaglutide (TA875) notes that treatment should be considered for up to a maximum of two years within a specialist weight management service. That framing reflects exactly this reality: the benefit is present while treatment continues, and the clinical question is whether long-term use is appropriate for your specific situation.

Are there good reasons to stop Wegovy, and how should you do it?

There are several legitimate reasons people stop. Side effects (particularly persistent nausea, vomiting or upper gastrointestinal symptoms) sometimes make continuing difficult. Wegovy is not recommended during pregnancy or while trying to conceive, so stopping before conception is the right clinical step. Planned surgery is another reason: your anaesthetist and surgical team need to know you are on a GLP-1 medicine, and your prescriber may advise pausing beforehand. Some people pause during periods when they cannot access the medicine or want a break with their prescriber's agreement.

Stopping itself is straightforward, there is no required taper. You simply do not take the next injection. The more important part is telling your prescriber before you stop, so they can advise on what to expect, whether to revisit treatment later, and whether any monitoring makes sense. If you stopped because of side effects, documenting those means a clinical team can assess whether restarting at a lower dose, switching medicines, or exploring a different approach makes sense. For questions about whether a specific health condition affects your suitability, our FAQs cover common scenarios.

If you want to explore restarting (or are unsure whether stopping is the right call) our guide to pausing and restarting Wegovy covers that decision in detail. And for those who stopped because injections were the barrier, it is worth knowing that oral semaglutide options now exist in the UK, which may be relevant to a conversation with a prescriber.

What should you do if you are thinking about stopping?

Talk to your prescriber first. That sounds like a simple answer, but it is the genuinely useful one. A prescriber can tell you whether your current dose and how long you have been on it affects the timing of stopping, whether there are clinical reasons to stay on longer, and what realistic expectations look like for the weeks and months ahead.

If you have Wegovy through nume, your prescriber is a named, GPhC-registered Independent Prescriber who reviews every clinical query, the same rigour that goes into your consultation also goes into supporting decisions mid-treatment. You do not need to wait for a scheduled repeat to raise a question. Reaching our clinical team is straightforward, and aftercare is included as part of the service.

For anyone who started Wegovy through a different provider and is unsure where to turn, a fuller breakdown of stopping Wegovy safely is available, including what to consider if you have a digestive condition that made treatment harder. There are also specific considerations if issues like acid reflux or IBS were a factor in your experience on treatment.

If after reading this you want a clinical view on your options, speak to our prescribers, the consultation is free, and there is no obligation to start or continue treatment.